Table 2.
Availability of medicines for treatment of PD in 123 pharmacies surveyed
| Category | Availability N = 123 (%) | Availability (Private Sector) n = 62 (%) | Availability (Public Sector) n = 61 (%) | P Value |
|---|---|---|---|---|
| l‐dopa formulations | 59 (48.0) | 47 (75.8) | 12 (19.7) | 0.000 |
| DRAs | 84 (68.3) | 56 (90.3) | 28 (45.9) | 0.000 |
| MAOIs | 10 (8.1) | 9 (14.5) | 1 (1.6) | 0.02 |
| COMT inhibitors | 3 (2.4) | 2 (3.2) | 1 (1.6) | 1.00 |
| Anticholinergics | 69 (56.1) | 48 (77.4) | 21 (34.4) | 0.000 |
| Atypical antipsychotics | 22 (17.9) | 17 (27.4) | 5 (8.2) | 0.009 |
| Antidepressants | 3 (2.4) | 3 (4.8) | 0 (0.0) | 0.24 |
| Antidementia | 41 (33.3) | 35 (56.5) | 6 (9.8) | 0.000 |
| Miscellaneous | See footnote | See footnote | See footnote | See footnote |
| Overalla (at least one category) | 93 (75.6) | 59 (95.2) | 34 (55.7) | 0.000 |
Footnote: Miscellaneous medications: fludrocortisone (1; 0.8%; private; P = 1.00), oxybutynin (26; 21.1%; private 24; P = 0.000), melatonin (13; 10.6%; private 12; P = 0.002), amantadine (4, 3.3%; private; P = 0.12), midodrine (0), apomorphine injection (0). P value comparing availability in private versus public pharmacy types. Atypical antipsychotics: clozapine, quetiapine, aripiprazole. Antidementia: memantine, donepezil, rivastigmine, galantamine. Antidepressants: nortryptilline, desipramine, imipramine.
a
Availability of at least one of the categories of medicines.